COMMUNIQUÉS West-GlobeNewswire

Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156
13/10/2026
Evaluating first-in-class asset to potentially address current obesity treatment deficiencies by promoting weight loss and preserving lean body mass WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Sironax, a global [...]
Opus Genetics to Present at the Chardan Annual Healthcare Conference
13/10/2026
RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
13/10/2026
Visara secures exclusive worldwide rights, excluding Greater China, from Wuhan Hiteck Biological Pharma to develop and commercialize HT006.2.2 Visara plans to develop HT006.2.2 as VIS-102, its second clinical-stage [...]
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
13/10/2026
Post-hoc Phase 2 data show greater bone mineral density (BMD) gains and anabolic effect with EB613 in postmenopausal women with baseline T-scores of ≤-2.5 (osteoporosis) versus T-scores of >-2.5 (osteopenia) These [...]
ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams
13/10/2026
A new AI-powered application replaces the yearly messaging or concept testing study with cost-effective, iterative tests that optimize every marketing asset using synthetic and real HCPs, delivering results in days [...]
VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress
13/10/2026
In vivo data confirm activation of prodrug payload inside tumor cells following systemic administration of BiTAC-ADC molecules leading to potent anti-tumor activity ZURICH, SWITZERLAND – October 13, 2026 -- VERAXA [...]
5 Questions People Ask When Every Weight Loss Approach Has Failed
13/10/2026
Trilivy's™ mission is lifelong transformation through metabolic science and human connection Baltimore, MD, Oct. 13, 2026 (GLOBE NEWSWIRE) -- When every weight loss approach has failed , individuals wonder what went [...]
Aclarion to Present at the 20th Annual LD Micro Main Event
13/10/2026
BROOMFIELD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard [...]
Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity
13/10/2026
Collaboration Demonstrates Substantially Higher Protein and Biomanufacturing Productivity While Producing Structured Cultivated Tissue HAIFA, Israel and EDINBURGH, Scotland, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Ever After [...]
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
13/10/2026
Combination cohorts are part of Prelude’s Phase 1 trial evaluating PRT13722 in patients with HR+/HER2- breast cancer, on track to initiate enrollment in the fourth quarter of 2026 The collaboration is underpinned by pre [...]
Mammogen Appoints Diagnostics Industry Leader, Dr. Robert S. Epstein, to Board of Directors
13/10/2026
Accomplished diagnostics and precision medicine leader brings decades of experience shaping the scientific, commercial and market success of category-defining companies across genomics, oncology and women's health [...]
nCAP Medical, Inc. Announces Distribution Agreement with Lovell Government Services, Inc. to Provide NeuroCuple® to Federal Healthcare Systems
13/10/2026
HEBER CITY, Utah, Oct. 13, 2026 (GLOBE NEWSWIRE) -- nCAP Medical, Inc. (“nCAP Medical” or the “Company”), a medical technology company developing NeuroCuple ® , a non-opioid platform for chronic and post-surgical pain, [...]
Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes
13/10/2026
– EASD findings support clinical evaluation of a next-generation oral menin inhibitor designed to restore insulin-producing capacity – – IND-enabling development underway to support Phase 1 clinical proof-of-concept [...]
Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
13/10/2026
WAYNE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies [...]
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
13/10/2026
Professor Philip Molyneaux will present on the patient-reported outcomes from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) NEW HAVEN, [...]
Repligen to Report Third Quarter 2026 Financial Results
13/10/2026
Webcast and Conference Call to Be Held Tuesday, October 27, 2026, at 8:00 a.m. ET WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announced that the Company will report its [...]
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
13/10/2026
BURLINGTON, Mass. and JERUSALEM, Oct. 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today [...]
Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
13/10/2026
TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its [...]
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
13/10/2026
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]

Pages